Literature DB >> 7096574

A chromatographic quality control procedure based on HPLC for 5-hydroxymethylfurfural in autoclaved D-glucose infusion fluids.

C T Hung, A B Selkirk, R B Taylor.   

Abstract

A specific qualitative chromatographic assay method is described for 5-hydroxymethylfurfuraldehyde (5HMF) in degraded D-glucose solutions incorporating an internal standard. Comparison is made between the chromatographic method and the official direct ultraviolet absorption measurements at 284 nm for solutions of D-glucose degraded to different extents. Hospital samples of autoclaved Dextrose Injection, 5% w/v, are also examined by both methods and it is demonstrated that quite different results can be obtained depending upon the conditions of measurement. It is demonstrated that the direct absorption method does not provide an adequate limit test for compounds related to 5HMF.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096574     DOI: 10.1111/j.1365-2710.1982.tb00903.x

Source DB:  PubMed          Journal:  J Clin Hosp Pharm        ISSN: 0143-3180


  4 in total

Review 1.  A critical appraisal of drug stability testing methods.

Authors:  R B Taylor; A S Shivji
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

2.  Factors Generating Glucose Degradation Products In Sterile Glucose Solutions For Infusion: Statistical Relevance Determination Of Their Impacts.

Authors:  J Haybrard; N Simon; C Danel; C Pinçon; C Barthélémy; F J Tessier; B Décaudin; E Boulanger; P Odou
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

3.  Degradation of furfural (2-furaldehyde) to methane and carbon dioxide by an anaerobic consortium.

Authors:  C J Rivard; K Grohmann
Journal:  Appl Biochem Biotechnol       Date:  1991       Impact factor: 2.926

4.  Identification and quantification of glucose degradation products in heat-sterilized glucose solutions for parenteral use by thin-layer chromatography.

Authors:  Sarah Leitzen; Matthias Vogel; Anette Engels; Thomas Zapf; Martin Brandl
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.